First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors

  1. Lookup NU author(s)
  2. Professor Ruth Plummer
  3. Dr Christopher Jones
  4. Lynsey Robson
  5. Professor Alan Calvert
Author(s)Plummer R, Middleton M, Wilson R, Jones C, Evans J, Robson L, Steinfeldt H, Kaufman R, Reich S, Calvert AH
Publication type Article
JournalJournal of Clinical Oncology
Issue16 Supplement 1
Pages208 no. 3065
ISSN (print)0732-183X
ISSN (electronic)1527-7755
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
NotesFirst presented at the 41st Annual Meeting of the American Society of Clinical Oncology, Orlando, Florida, USA. 13-17 May, 2005.
Actions    Link to this publication